Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Hawley

Showing results (171-180 of 174) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 174 results.
Journal of Natural Products|January 31, 2024
Neopetrotaurines A-C, Isoquinoline Alkaloids with an Unprecedented Taurine Bridge from the Sponge <i>Neopetrosia</i> spDongdong Wang, Wei Jiang, Mehal Churiwal, et al.
JCO Precision Oncology|June 8, 2026
Combination of Selpercatinib and Trametinib Overcomes Resistance to RET Inhibitors in RET-Mutant Medullary Thyroid CarcinomaDavid Milewski, Arwa Fallatah, Maya Groff, et al.
Neuro-Oncology Advances|September 14, 2023
Combined inhibition of topoisomerase I and poly(ADP-ribose) polymerase: A synergistic therapeutic strategy for glioblastoma with phosphatase and tensin homolog deficiencyOlga Kim, Madison Butler, Zach Sergi, et al.
Nature Communications|February 24, 2024
KDM3B inhibitors disrupt the oncogenic activity of PAX3-FOXO1 in fusion-positive rhabdomyosarcomaYong Yean Kim, Berkley E Gryder, Ranuka Sinniah, et al.
Pageof 18

Showing results (171-180 of 174) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 174 results.
Journal of Natural Products|January 31, 2024
Neopetrotaurines A-C, Isoquinoline Alkaloids with an Unprecedented Taurine Bridge from the Sponge <i>Neopetrosia</i> spDongdong Wang, Wei Jiang, Mehal Churiwal, et al.
JCO Precision Oncology|June 8, 2026
Combination of Selpercatinib and Trametinib Overcomes Resistance to RET Inhibitors in RET-Mutant Medullary Thyroid CarcinomaDavid Milewski, Arwa Fallatah, Maya Groff, et al.
Neuro-Oncology Advances|September 14, 2023
Combined inhibition of topoisomerase I and poly(ADP-ribose) polymerase: A synergistic therapeutic strategy for glioblastoma with phosphatase and tensin homolog deficiencyOlga Kim, Madison Butler, Zach Sergi, et al.
Nature Communications|February 24, 2024
KDM3B inhibitors disrupt the oncogenic activity of PAX3-FOXO1 in fusion-positive rhabdomyosarcomaYong Yean Kim, Berkley E Gryder, Ranuka Sinniah, et al.
Pageof 18